Ondansetron B. Braun 0.08/0.16 mg/ml solution for infusion

B. Braun SE

Product Keywords

Antiemetic for intravenous infusion

Product Description:


  • Prevention and treatment of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy (CINV/RINV)
  • Prevention and treatment of post-operative nausea and vomiting (PONV).

Paediatric population

  • Management of chemotherapy-induced nausea and vomiting (CINV) in children aged ≥ 6 months
  • Prevention and treatment of postoperative nausea and vomiting (PONV) in children aged ≥ 1 month.

Available in:

  • Ondansetron 0.08 mg/ml: Ecoflac® plus 100 ml
  • Ondansetron 0.16 mg/ml: Ecoflac® plus 50 ml


  • MHRA advice for healthcare professionals to dilute Ondansetron and infuse over at least 15 minutes for patients age 65 years or older.
  • Ready-to-use dose product eliminates intermediate steps and helps to prevent dosage errors.

More Solutions:

Related Solutions:

No results
2Contact Person
3Contact Details